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Purpose: To formulate rifabutin-loaded floating gel beads for stomach-specific release. 
Methods: Rifabutin-loaded floating gellan gum beads were prepared by ionotropic calcium-induced 
gelation in acidic medium. In-vitro buoyancy and drug release studies were performed using a USP 
dissolution apparatus type II in 0.01M HCl (ph 2.0) as the dissolution medium. The shape, surface 
morphology and internal structure of the dried beads were examined by scanning electron microscopy. 
Fourier Transform infrared spectroscopy (FTIR) was applied to investigate drug-polymer interactions. 
Results: The beads exhibited excellent buoyancy in simulated gastric fluid (SGF) and remained 
buoyant for 18 h. Drug incorporation efficiency of the beads ranged from 40 to 60 % and was dependent 
significantly (p < 0.05) on the concentrations of calcium ions and gellan gum. Drug release from the 
floating bead formulations was rapid, with > 50 % of the drug released within 1 h. Increased polymer 
concentration did not significantly (p < 0.05) retard drug release. 
Conclusion: Incorporation efficiency and release of rifabutin can be controlled by modulation of the 
investigated parameters. The developed floating gellan gum beads may be suitable for a potential oral 
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INTRODUCTION 
 
Gellan gum is a bacterial exopolysaccharide 
commercially prepared by aerobic 
submerged fermentation of Sphingomonas 
elodea. There are two chemical forms of 
gellan gum: native or natural form, which has 
high acyl contents, and low or deacetylated 
form [1]. In the presence of counterions, this 
polymer is capable of forming gels that are 
particularly strong when formed with divalent 
ions. The degree of acylation also influences 
the strength of the resulting network. Indeed, 
in its native form, gellan is acylated and it 
forms soft, elastic, transparent and flexible 
gels while de-acylation leads to hard, non-
elastic and brittle gels [2]. 
 
The gelling mechanism of gellan can be 
induced by cations and is temperature-
dependent. In aqueous solution, the gelation 
of gellan is accompanied by a two-step 
process, namely, formation of double helices 
from random coil chains and an aggregation 
of pairs of double helices[3]. The coil–helix 
transition is greatly affected by electrostatic 
interaction with cations present in the 










) but its affinity for the latter is 
much stronger than for the former [1]. A 
number of efforts have been made to 
understand the mechanism of 
microencapsulation of gellan gum in the 
presence of calcium cations but the exact 
mechanism remains unknown [2,3].  
 
The objective of this study was to evaluate 
the effect of calcium ions on the 
encapsulation efficiency of deacylated gellan 






Rifabutin was obtained from Henan Kangtai 
Pharm Group, China. Deacetylated gellan 
gum (Kelcogel) was obtained as a gift from 
CP Kelco, UK Ltd, Surrey, U.K. De-ionized 
water (HPLC grade) purchased from 
Quilagens, India was used. All other 
chemicals used were of AR grade. 
 
Preparation of floating beads 
 
The beads, whose composition is shown in 
Table 1, were prepared by ionotropic gelation 
technique [4] with some modification. Gellan 
solution (1 – 3 % w/v) was prepared by 
dissolving gellan in deionized water at 90 °C. 
The drug, rifabutin, and sodium bicarbonate 
were dissolved/dispersed uniformly in the 
gellan solution at or just below 40 °C with 
continuous stirring until a uniform dispersion 
was obtained. The bubble-free slurry 
(dispersion) was added drop-wise into the 
gelation medium consisting of varying 
concentrations of Ca
2+
 in 10 % v/v acetic acid 
with a 25 ml hypodermic syringe through a 20 
G needle into the gelation medium. The 
medium was continuously stirred during bead 
formation to enhance the mechanical 
strength of the beads and also to prevent 
their aggregation. The beads were cured for 
5 min, separated by filtration, washed thrice 
with deionized water and dried at 40 °C in a 
hot air oven (DR 101, Universal, India).  
 
Determination of drug incorporation 
efficiency 
 
The drug incorporation efficiency of each 
formulation was determined by first extracting 
rifabutin from an accurately weighed quantity 
(100 mg) of the beads using 0.01M HCl (pH 
2.0) and determining the amount of the drug 
by high performance liquid chromatography 
(HPLC).  
 
For HPLC determination of drug, the mobile 
phase consisted of 0.05M potassium 
dihydrogen phosphate and sodium acetate 
(pH adjusted to 4.0 with acetic acid)/ 
acetonitrile (53:47, v/v) at a flow rate of 1 
ml/min at 25 °C. The HPLC system 
(Shimadzu, SPD-20A detector, LC-20AT 
pump) consisted of a UV detector set to 275 
nm and Pursuit XRs C-8 analytical column 
(USP-L7). 
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A standard solution of rifabutin (100 µg/ml) 
was prepared by weighing the appropriate 
amount of bulk rifabutin and dissolving it in 
the mobile phase. Further stock solutions 
were made by diluting the initial stock 
standard solution with mobile phase. A 
seven-point calibration curve ranging from 1 
to 7 µg/ml was used for the quantification of 
rifabutin. A stock solution of 1.0 µg/ml was 
stored at −30 
0
C and a sample of this stock 
solution was always injected together with the 
analyzed samples to verify the precision of 
the obtained concentrations of rifabutin in 





Fourier Transform Infrared Spectroscopy 
(FTIR) was employed to study drug-polymer 
interactions. Spectra were recorded for the 
pure drug and drug-loaded beads using a 
FTIR facility (Shimadzu, model 8400S). The 
samples were prepared in KBr disks (2 mg 
sample in 200 mg KBr). The scanning range 
was 400 - 4000 cm
-1





Assessment of in vitro buoyancy of the 
beads 
 
In vitro study of bead bouyancy was 
performed using a USP dissolution apparatus 
type II (paddle type, Electrolab, Mumbai, 
India). The beads were dispersed in 500 ml 
of 0.01M HCl (pH 2.0) at 37 ± 1 
0
C with 
continuous agitation at 50 rpm for 24 h. The 
floating beads were separated from the 
submerged beads and their proportion (%) 
was determined as described earlier [3,4]. 
 
Morphology and bead size analysis 
 
The size of the beads was determined with 
an optical microscope (Model BH-2, 
Olympus, Japan) fitted with a stage and an 
ocular micrometer. Twenty dried beads were 
measured in order to determine the mean 
diameter of the beads. All measurements 
were in triplicate. The shape, surface 
morphology and internal structure of the dried 
beads were assessed with a scanning 
electron microscope (Leo 435VP, variable 
pressure, Oxford, U.K.) at various magni-
fications. 
 
In vitro drug release studies 
 
In vitro release of rifabutin from the beads 
was evaluated with a USP dissolution 
apparatus type II (paddle type, Electrolab, 
Mumbai, India) at 50 rpm. in 500 ml 0.01M 
HCl (pH 2.0) at 37 ± 0.5 
0
C, as per USP 
monograph for rifabutin capsules. At 
predetermined intervals, a 1-ml aliquot was 
withdrawn and replenished with an equal 
volume of fresh dissolution medium [5] .The 
withdrawn samples were analyzed by HPLC 
as described earlier. 
 
Determination of mechanism of drug 
release 
 
The in vitro data were fitted to Higuchi’s 
square root model [6] to analyze the kinetics 
of drug release from the beads (see Eq 1)  
 
 
Q = K√t,  ……………..……………………. (1) 
 
 
where Q is the amount of the drug released 
in time, t, K is the release constant of the 
equation. The data were also subjected to 
Korsmeyer-Peppas power law[7,8] as in Eq 
2. 
 
Mt/M∞ = Ktn …………………  …….…….. (2) 
 
 
where Mt/M∞ is the fraction of drug released 
in time, t, K is the structural and geometric 




All the data were analyzed by Student’s t-test 
and one-way ANOVA to determine statistical 
difference in the results. A probability value of 
p < 0.05 was considered statistically 
significant. The software used was 
SigmaPlot
®
 11 (Systat Software Inc). 
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Morphological properties and size of 
beads 
 
The scanning electron micrographs (SEM) of 
rifabutin-loaded gellan beads are shown in 
Fig 1. The beads were spherical but exhibited 
a rough surface. The transverse section of 
the beads revealed a very porous interior. 
The mean bead diameter data, shown in 
Table 2, indicate that (at low calcium 
concentration) as the amount of gellan gum 
in the beads increased, diameter also 
increased (p < 0.05). However, there were no 
significant difference in bead size when the 
concentration of either calcium chloride or 
crosslinking agent was varied. 
 
    
(a)             (b)                (c)      
 
Figure 1: Scanning electron microscopy images of 
rifabutin-loaded bead: (a) shape (b) surface 
morphology (c) transverse section  
 
Table 1: Composition of floating rifabutin beads  
Each batch also contained 1.0 and 0.4 % rifabutin and 
sodium bicarbonate, respectively) 
 
 
Table 2: Some physiochemical characteristics of 













A1 1.26±0.04 40.3±1.4 98.8±1.8 0.53 
A2 1.22±0.06 44.7±1.4 96.7±2.0 0.54 
A3 1.20±0.05 48.9±1.3 94.7±1.9 0.41 
A4 1.46±0.02 46.1±1.2 97.1±1.8 0.41 
A5 1.42±0.05 48.7±1.3 95.3±2.1 0.41 
A6 1.40±0.05 53.9±1.3 92.4±1.8 0.42 
A7 1.52±0.03 48.6±1.2 95.8±1.7 0.45 
A8 1.49±0.03 53.9±1.3 94.4±1.9 0.46 
A9 1.48±0.02 60.7±1.2 90.2±1.7 0.46 
 
Drug entrapment (incorporation 
efficiency) of rifabutin beads 
 
Rifabutin entrapment ranged from 40.3 to 
60.7 % (see Table 2). Drug entrapment 
efficiency varied with polymer content and the 
calcium concentration of the gelation 
medium. Increase in calcium concentration 
enhanced drug encapsulation efficiency (p < 
0.05, compare batches A1 and A3; A4 and 
A6; and A7 and A9). Similarly, as the 
concentration of gellan gum rose, entrapment 
efficiency also increased (compare A1 and 
A7; and A2 and A8). Overall, however, 
rifabutin-entrapment efficiency of the beads 




The FTIR spectra of rifabutin, gellan gum, 
their physical mixtures and beads (not 
shown) indicate that there was no interaction 
between the drug and gellan. 
 
In vitro bead buoyancy 
 
As Table 2 shows, the floating properties of 
the formulations depended largely on sodium 
bicarbonate. While the control beads (without 




(%w/v) CaCl2 (%w/v) 
A1 1 3 
A2 1 4 
A3 1 5 
A4 2 3 
A5 2 4 
A6 2 5 
A7 3 3 
A8 3 4 
A9 3 5 
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medium, the beads containing 0.4 % 
NaHCO3 demonstrated good floating 
characteristics. There was no lag time as the 
beads floated immediately when placed in 
0.01M HCl and remained so for up to 18 h.  
 
In vitro drug release properties 
 
Rifabutin release from four of the bead 
formulations in 0.01M HCl (pH 2.0) is shown 
in Fig 2. Release decreased (p < 0.05) with 
increase in calcium concentration and was 
characterized by an initial phase of rapid 
release (burst effect) due to the good 
solubility of the drug in the dissolution 
medium, followed by slow release of the 
drug. No significant difference (p < 0.05) in 
drug release was observed when gellan gum 
content was varied. Overall drug release from 
the beads was rapid, with 48 – 69 % released 
within the first hour. 
 
 
Figure 2:  Cumulative rifabutin release from 
floating beads containing 2%/3% gellan/CaCl2 (A4, 
♦), 2%/5% gellan/CaCl2 (A6, □), 3%/3% 
gellan/CaCl2 (A7, ∆), 3%/5% gellan/CaCl2 (A9, x). 
Note: *p < 0.05 in comparison to A4 and **p < 





The numerous pores in the bead interior may 
be directly related to the presence of sodium 
bicarbonate and is in agreement with the 
findings of Choi et al [4]. The increase in 
bead size with increasing gellan 
concentration could be attributed to increase 
in microviscosity of the polymeric dispersion, 
leading eventually to the formation of bigger 
beads [9].  
 
The low drug entrapment efficiency of the 
beads may be due to the use of sodium 
bicarbonate as gas-generating agent, which 
on reacting with acetic acid, released carbon 
dioxide. The released carbon dioxide gets 
entrapped in the gel network, thus increasing 
bead porosity and decreasing the strength of 
the bead wall. As a result, the drug readily 
diffuses out into the gelation fluid. Stockwell 
and Davis [10] also attributed the low 
entrapment efficiency of alginate beads to 
violent gas generation. 
  
Another reason for the low drug incorporation 
efficiency could be that metal cations exhibit 
a specific topological signature in the electron 
localization of their density interaction with 
ligands according to their "soft" or "hard" 
character”. The degree of softness or 
hardness refers to the electron mobility or 
polarizability of a species. According to 
Pearson's Hard Soft Acid Base Principle [11] 
and Klopman's FMO (frontier molecular 
orbitals) analysis [12], hard acids tend to form 
strong bonds with hard bases to give charge-
controlled (ionic) complexes whereas soft 
acids tend to form strong bonds with soft 
bases to give FMO-controlled (covalent) 
complexes.  In the present study, the hard 
base and hard acid are calcium ions and the 
COO
-
 group on the gellan network, 
respectively. Therefore, interaction between 
calcium and the carboxylate group on the 
gellan molecule will be most preferred, but 
water is known to hamper hard acid-hard 
base interactions [13], being itself a hard 
base and therefore, competes with calcium 
ions. This could have hindered the approach 
of calcium ions to the COO
- 
group, thus 
resulting in the formation of weak complexes 
that could not retain rifabutin adequately. 
Hence also, as the concentration of calcium 
in the gelation medium increased, the greater 
the amount of calcium ions available for 
reaction with COO
-
 group; this might have 
resulted in strong aggregation of pairs of 
helices, leading to stronger gel structures that 
held more of the drug.  
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The increase in the drug entrapment 
efficiency of beads with increasing polymer 
concentration may be because increase in 
the gellan concentration resulted in the 
formation of larger beads which entrapped 
more drug. Furthermore, higher polymer 
concentration affords higher viscosity, which 
would hinder easy escape of the drug from 
the polymer matrix to the gelation medium. 
     
Beads were floated in 0.01M HCl for 18 h. 
Upon contact with acid medium, sodium 
bicarbonate effervesces, releasing carbon 
dioxide. In this case, the released carbon 
dioxide was most likely entrapped in the bead 
gel network produced by the reaction of the 
calcium ions present in the gelation medium 
with gellan. The crosslinked three-
dimensional gel network would have 
restricted the outward diffusion of carbon 
dioxide, leading to an extended period of 
bouyancy.  
 
Rifabutin release  
 
The mechanism of crosslinking or gelation of 
gellan gum with calcium chloride is based on 
the formation of double helical junction zones 
followed by aggregation of double helical 
segments to form a three dimensional 
network by complexation with cations [14]. 
However, gellan [2] and alginate-based 
matrix drug delivery systems [15-17] often 
suffer from rapid drug release such as was 
observed in the present study. The reason for 
the rapid release may be explained by the 
fact that gelation and aggregation of gellan 
gum occur via chemical bonding between 
calcium and carboxylic groups in the gellan 
chains. Calcium, being a hard electrophile, 
interacts with the carboxylate group of gellan 
gum electrostatically. Such interactions tend 
to be readily hydrated and thus broken under 
aqueous conditions, resulting in rapid release 
of drug from the beads [18].  
As the concentration of gellan gum 
increased, more carboxylate group side 
chains would be available for the formation of 
a stronger gellan-calcium network. However, 
this appeared not be the case in this study 
because increasing gellan concentration did 
not result in the expected reduction in the 
drug release of the beads. No significant 
difference (p < 0.05) in drug release was 
observed as gellan content was increased. 
This may be due to the inadequate 
availability of calcium ions for cross-linking 
with gellan in the beads. 
 
Drug release mechanism 
 
The range of correlation coefficient (r
2
) values 
for various release models applied to the 
release data were as follows: 0.7515 - 0.8737 
(zero order), 0.8954 – 0.8432 (1
st
 order), and 
0.9447 – 0.9926 (Higuchi). This suggests that 
drug release from the beads predominantly 
followed Higuchi model as the r
2
 values  were 
higher than for other models. When the in-
vitro drug release data were fitted to the 
exponential equation Mt/M∞=Kt
n
, it was found 
that drug release also followed an anomalous 
non-Fickian diffusion pattern, as indicated by 
the release exponent values (n) which were 




Since the incorporation efficiency and drug 
release could be controlled by the regulation 
of the process factors, floating gellan gum 
beads can be further developed for use as a 
oral stomach-specific release system for the 
treatment of stomach-specific infections such 
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